HEALTHSTORY 545· JUNE 29, 2026

Australian Musician's U.S. Tour Break Ends With a Quintessentially American Hospital Bill

An Australian musician who broke her back while on tour in the United States spent nearly two weeks in an American hospital, then published an account of the experience. Her dispatch was described as surprisingly heartwarming — the medical…

NDNewsDialy Desk1 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 544KBR Wins License and Engineering Deal for Asia's First Commercial-Scale Ethanol-to-Jet SAF Plant NEXT STORY 546 →Global M&A Hits $2.4 Trillion Through May as Bain Flags AI "Winner's Paradox" for Acquirers

Keep reading

More from the desk.

10HEALTH

FDA clears Replimune's melanoma drug Tudriqev after two rejections

A cancer treatment rejected twice by federal regulators has now won approval. The Food and Drug Administration granted accelerated approval to Tudriqev, a drug made by the biotech company Replimune, for patients with advanced melanoma…

health2 MIN

48HEALTH

Seven months after launch, Aurora Therapeutics scraps its lead gene-editing program and cuts staff

Personalized CRISPR therapies, gene-editing treatments built around one patient's specific mutation rather than a disease shared by millions, just lost one of their early backers. Aurora Therapeutics has scrapped its lead program and laid…

health2 MIN

63HEALTH

California Supreme Court rules Gilead Sciences has no legal duty to fast-track a safer HIV drug

Pharmaceutical companies do not owe patients a legal duty to speed up development of a safer drug simply because a less safe version is already on the market. That concept, called a "duty to innovate," was at the center of a case brought…

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk